metformin has been researched along with Lymphoma in 6 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lymphoma and pancreatic cancer patients with type 2 diabetes were sorted into an experimental (metformin) group and a control (nonmetformin) group." | 7.91 | Metformin Associated With Increased Survival in Type 2 Diabetes Patients With Pancreatic Cancer and Lymphoma. ( Solomon, SS; Vacheron, A; Wynn, A; Zuber, J, 2019) |
| "Metformin showed synergistic cytotoxic effects in combination with dacarbazine, reduced cell viability, and increased apoptosis in Raji and Ramos lymphoma cells in comparison with the use of each drug alone." | 7.88 | The Role of SAPK/JNK Pathway in the Synergistic Effects of Metformin and Dacarbazine on Apoptosis in Raji and Ramos Lymphoma Cells. ( Iranshahi, M; Naserian, M; Ramazani, E; Tayarani-Najaran, Z, 2018) |
| "Lymphoma and pancreatic cancer patients with type 2 diabetes were sorted into an experimental (metformin) group and a control (nonmetformin) group." | 3.91 | Metformin Associated With Increased Survival in Type 2 Diabetes Patients With Pancreatic Cancer and Lymphoma. ( Solomon, SS; Vacheron, A; Wynn, A; Zuber, J, 2019) |
| "Metformin showed synergistic cytotoxic effects in combination with dacarbazine, reduced cell viability, and increased apoptosis in Raji and Ramos lymphoma cells in comparison with the use of each drug alone." | 3.88 | The Role of SAPK/JNK Pathway in the Synergistic Effects of Metformin and Dacarbazine on Apoptosis in Raji and Ramos Lymphoma Cells. ( Iranshahi, M; Naserian, M; Ramazani, E; Tayarani-Najaran, Z, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bonglack, EN | 1 |
| Messinger, JE | 1 |
| Cable, JM | 1 |
| Ch'ng, J | 1 |
| Parnell, KM | 1 |
| Reinoso-Vizcaíno, NM | 1 |
| Barry, AP | 1 |
| Russell, VS | 1 |
| Dave, SS | 1 |
| Christofk, HR | 1 |
| Luftig, MA | 1 |
| Beloueche-Babari, M | 1 |
| Wantuch, S | 1 |
| Casals Galobart, T | 1 |
| Koniordou, M | 1 |
| Parkes, HG | 1 |
| Arunan, V | 1 |
| Chung, YL | 1 |
| Eykyn, TR | 1 |
| Smith, PD | 1 |
| Leach, MO | 1 |
| Naserian, M | 1 |
| Ramazani, E | 1 |
| Iranshahi, M | 1 |
| Tayarani-Najaran, Z | 1 |
| Cunha Júnior, AD | 1 |
| Pericole, FV | 1 |
| Carvalheira, JBC | 1 |
| Wynn, A | 1 |
| Vacheron, A | 1 |
| Zuber, J | 1 |
| Solomon, SS | 1 |
| Popovich, IG | 1 |
| Piskunova, TS | 1 |
| Tyndyk, ML | 1 |
| Anikin, IV | 1 |
| Zabezhinskiĭ, MA | 1 |
| Anisimov, VN | 1 |
1 review available for metformin and Lymphoma
| Article | Year |
|---|---|
Metformin and blood cancers.
Topics: Body Mass Index; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin; Leukemia; Lymphoma | 2018 |
5 other studies available for metformin and Lymphoma
| Article | Year |
|---|---|
Monocarboxylate transporter antagonism reveals metabolic vulnerabilities of viral-driven lymphomas.
Topics: B-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Epstein-Barr Virus Infections; Glucose; Glutath | 2021 |
MCT1 Inhibitor AZD3965 Increases Mitochondrial Metabolism, Facilitating Combination Therapy and Noninvasive Magnetic Resonance Spectroscopy.
Topics: Acrylates; Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cell Line, Tu | 2017 |
The Role of SAPK/JNK Pathway in the Synergistic Effects of Metformin and Dacarbazine on Apoptosis in Raji and Ramos Lymphoma Cells.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Dru | 2018 |
Metformin Associated With Increased Survival in Type 2 Diabetes Patients With Pancreatic Cancer and Lymphoma.
Topics: Aged; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Lymphoma; Male; Metformin; Mid | 2019 |
[Metformin effect on urethane-induced tumorigenesis in mice].
Topics: Adenoma; Administration, Oral; Animals; Anticarcinogenic Agents; Carcinogens; Cell Transformation, N | 2012 |